News & Events

Mebane, NC (May 20, 2010) –  BD (Becton, Dickinson and Company), a leading global medical technology company, today celebrated the grand opening of its newest BD Diagnostics production facility in Mebane, North Carolina. To date, BD has invested $14 million in the 101,000-square-foot facility in Alamance County, which will employ 75 associates, creating 30 new jobs for the County. The new facility provides added manufacturing capacity for diagnostic products that support BD’s Women’s Health and Cancer strategy. 

“BD began operations in Alamance County in 2006 with the acquisition of TriPath Imaging,” said Wayne Brinster, VP/GM of Women’s Health and Cancer, BD. “Our expansion in Mebane is evidence of our positive experience with the skilled workforce and economic environment here. BD is very pleased to be growing in North Carolina, where we have had operations since 1972, and we appreciate the strong support we have received from the local authorities for this investment.”

BD’s Women’s Health and Cancer platform is committed to developing and providing advanced instruments and reagents to improve disease detection as well as laboratory performance and workflow. The Mebane facility is the second BD Diagnostics plant in North Carolina. The BD facility in Burlington is the largest manufacturing plant for the BD’s cervical cancer screening products and also houses management and operation functions.  BD is maintaining this facility, where it employs approximately 100 associates.

BD employs approximately 850 associates in North Carolina at four locations: BD Technologies in Research Triangle Park; BD Biosciences in Durham; and BD Diagnostics in Burlington, Research Triangle Park and Mebane. BD is also developing a manufacturing facility in Wilson.

About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in FranklinLakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.